The new news(Macrochem Acquires Option To License Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infection, from Genaera) tells me that there is money in the treatment of infected feet , Macrochem's (sepa) combined with Pexiganan could make it a winning combination.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.